Filing Details
- Accession Number:
- 0001181431-11-034531
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-03 09:00:30
- Reporting Period:
- 2011-06-01
- Filing Date:
- 2011-06-03
- Accepted Time:
- 2011-06-03 09:00:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1338042 | Aegerion Pharmaceuticals Inc. | AEGR | Pharmaceutical Preparations (2834) | 202960116 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1314575 | D Marc Beer | C/O Aegerion Pharmaceuticals, Inc. 101 Main Street, Ste 1850 Cambridge MA 02142 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-06-01 | 4,162 | $18.69 | 115,582 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-06-01 | 1,170 | $18.73 | 116,752 | No | 4 | P | Indirect | Roth IRA |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | Roth IRA |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2011-06-01 | 115,000 | $0.00 | 115,000 | $17.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,000,653 | 2021-06-01 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 111,420 | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2011.
- The shares of common stock underlying this stock option vest in equal monthly installments over a four year period beginning on June 1, 2011.
Billionaire Hedge Funds
